AAAAAA

   
Results: 1-7 |
Results: 7
Relation between HIV-1 and hepatitis C viral load in patients with hemophilia
Authors: Daar, ES Lynn, H Donfield, S Gomperts, E Hilgartner, MW Hoots, WK Chernoff, D Arkin, S Wong, WY Winkler, CA
Citation: Es. Daar et al., Relation between HIV-1 and hepatitis C viral load in patients with hemophilia, J ACQ IMM D, 26(5), 2001, pp. 466-472
Hepatitis c virus load is associated with human immunodeficiency virus type 1 disease progression in hemophiliacs
Authors: Daar, ES Lynn, H Donfield, S Gomperts, E O'Brien, SJ Hilgartner, MW Hoots, WK Chernoff, D Arkin, S Wong, WY Winkler, CA
Citation: Es. Daar et al., Hepatitis c virus load is associated with human immunodeficiency virus type 1 disease progression in hemophiliacs, J INFEC DIS, 183(4), 2001, pp. 589-595
Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis
Authors: Babiker, A Darby, S De Angelis, D Kwart, D Porter, K Beral, V Darbyshire, J Day, N Gill, N Coutinho, R Prins, M van Benthem, B Coutinho, R Dabis, F Marimoutou, C Ruiz, I Tusell, J Altisent, C Evatt, B Jaffe, H Kirk, O Pedersen, C Rosenberg, P Goedert, J Biggar, R Melbye, M Brettie, R Downs, A Hamouda, O Touloumi, G Karafoulidou, A Katsarou, O Donfield, S Gomperts, E Hilgartner, M Hoots, K Schoenbaum, E Beral, V Zangerle, R Del Amo, J Pezzotti, P Rezza, G Hutchinson, S Day, N De Angelis, D Gore, S Kingsley, L Schrager, L Rosenberg, P Goedert, J Melnick, S Koblin, B Eskild, A Bruun, J Sannes, M Evans, B Lepri, AC Sabin, C Buchbinder, S Vittinghoff, E Moss, A Osmond, D Winkelstein, W Goldberg, D Boufassa, F Meyer, L Egger, M Francioli, P Rickenbach, M Cooper, D Tindall, B Sharkey, T Vizzard, J Kaldor, J Cunningham, P Vanhems, P Vizzard, J Kaldor, J Learmont, J Farewell, V Berglund, O Mosley, J Operskalski, E van den Berg, M Metzger, D Tobin, D Woody, G Rusnak, J Hendrix, C Garner, R Hawkes, C Renzullo, P Garland, F Darby, S Ewart, D Giangrande, P Lee, C Phillips, A Spooner, R Wilde, J Winter, M Babiker, A Darbyshire, J Evans, B Gill, N Johnson, A Phillips, A Porter, K Lorenzo, JI Schechter, M
Citation: A. Babiker et al., Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis, LANCET, 355(9210), 2000, pp. 1131-1137
Effects of high-dose intravenous immunoglobulin on virus load in HIV-infected children
Authors: Church, JA Fox, S Gomperts, E
Citation: Ja. Church et al., Effects of high-dose intravenous immunoglobulin on virus load in HIV-infected children, J ACQ IMM D, 22(3), 1999, pp. 309-311
Effects of plasma HIV RNA, CD4(+) T lymphocytes, and the chemokine receptors CCR5 and CCR2b on HIV disease progression in hemophiliacs
Authors: Daar, ES Lynn, H Donfield, S Gomperts, E Hilgartner, MW Hoots, K Chernoff, D Winkler, C O'Brien, SJ
Citation: Es. Daar et al., Effects of plasma HIV RNA, CD4(+) T lymphocytes, and the chemokine receptors CCR5 and CCR2b on HIV disease progression in hemophiliacs, J ACQ IMM D, 21(4), 1999, pp. 317-325
Pharmacokinetics of recombinant factor VIII (recombinate) using one-stage clotting and chromogenic factor VIII assay
Authors: Lee, CA Owens, D Bray, G Giangrande, P Collins, P Hay, C Gomperts, E Schroth, P Barrowcliffe, T
Citation: Ca. Lee et al., Pharmacokinetics of recombinant factor VIII (recombinate) using one-stage clotting and chromogenic factor VIII assay, THROMB HAEM, 82(6), 1999, pp. 1644-1647
Reduced risk of AIDS lymphoma in individuals heterozygous for the CCR5-Delta 32 mutation
Authors: Dean, M Jacobson, LP McFarlane, G Margolick, JD Jenkins, FJ Howard, OMZ Dong, HF Goedert, JJ Buchbinder, S Gomperts, E Vlahov, D Oppenheim, JJ O'Brien, SJ Carrington, M
Citation: M. Dean et al., Reduced risk of AIDS lymphoma in individuals heterozygous for the CCR5-Delta 32 mutation, CANCER RES, 59(15), 1999, pp. 3561-3564
Risultati: 1-7 |